BIOMAT Database Logo BIOMAT Database Logo

[Prevention of RH-erythroblastosis by anti-D-application to the mother]. 1968

M Stahl, and W Althoff, and G Schellong

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

M Stahl, and W Althoff, and G Schellong
[Erythroblastosis in an Rh negative newborn infant of an Rh negative mother with anti-D antibodies].
March 1954, Acta chirurgica Belgica,
M Stahl, and W Althoff, and G Schellong
[Prevention of Rh sensitization by means of anti D application].
January 1969, Bibliotheca haematologica,
M Stahl, and W Althoff, and G Schellong
Prevention of erythroblastosis with anti-rh gamma globulin.
March 1970, California medicine,
M Stahl, and W Althoff, and G Schellong
Review: anti-Rh immunoglobulin in prevention of erythroblastosis fetalis.
May 1969, The Journal of the Oklahoma State Medical Association,
M Stahl, and W Althoff, and G Schellong
[Prevention of fetal Rh erythroblastosis].
May 1969, L'union medicale du Canada,
M Stahl, and W Althoff, and G Schellong
[Prevention of fetal erythroblastosis with anti-D immunoglobulin].
January 1988, Acta haematologica Polonica,
M Stahl, and W Althoff, and G Schellong
Prevention of Rh haemolytic disease by immunoglobulin anti-D.
January 1983, Vox sanguinis,
M Stahl, and W Althoff, and G Schellong
The prevention of erythroblastosis fetalis by the use of Rh hapten.
October 1952, Southern medical journal,
M Stahl, and W Althoff, and G Schellong
Prevention of Rh isoimmunization by injection of anti-D antibody.
December 1967, Obstetrics and gynecology,
M Stahl, and W Althoff, and G Schellong
[Prevention of serological conflict due to Rh factor incompatibility by administration of domestic anti-Rh (D) immunoglobulin].
December 1968, Ginekologia polska,
Copied contents to your clipboard!